Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.
about
Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria.A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.Cloning of type 8 capsule genes and analysis of gene clusters for the production of different capsular polysaccharides in Staphylococcus aureus.Staphylococcus aureus capsular polysaccharides.Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.MsaB activates capsule production at the transcription level in Staphylococcus aureus.MgrA activates expression of capsule genes, but not the α-toxin gene in experimental Staphylococcus aureus endocarditis.The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.
P2860
Q33965596-845E3098-C250-42CA-B28F-130529907EF7Q33991770-2D5B19BB-55FE-424F-A642-42FFC9C71295Q34112608-94431656-C567-4EF2-8EF6-ECD5B74B10DBQ34492747-7CF2A37E-0A13-4CB8-B9C0-AF1F0EE2FE5BQ34508443-96CBDFDD-7F53-45E5-884F-DED13442B913Q35489404-8C56C488-FBF2-4CD2-A754-C84C21D8A4C2Q35605034-C2B5FCBD-2928-4CAE-AF54-6450E96E25B5Q35630504-46F04DA7-0D10-4839-9758-B5FC43E3C576Q36486860-EB528BCA-4B52-44E8-80B0-1C4BDB721B80Q36966028-54DE548A-223C-4376-AAD2-4FE632F916F0Q37272332-C831C16C-11AB-44B4-9F18-57972B3F89D6Q38876259-05CE8D4C-2D0A-4121-B627-52BFEDF54708Q39831180-A1B0FD59-BADC-4C5D-AF83-B227585657EEQ39831208-97A334F6-F151-4ADB-BA50-2A9917DA9C83
P2860
Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@ast
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@en
type
label
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@ast
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@en
prefLabel
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@ast
Antibodies to capsular polysac ...... ylococcus aureus endocarditis.
@en
P2860
P1476
Antibodies to capsular polysac ...... hylococcus aureus endocarditis
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z